Significant progress has been made in the surgical treatment of neonatal congenital heart disease in China. According to the latest report from the National Center for Cardiovascular Diseases, the number of neonatal congenital heart disease surgeries nationwide exceeded 12,000 cases in 2023, with a surgical success rate of over 95%. Among these, top centers such as Shanghai Children's Medical Center and Fuwai Hospital have maintained success rates above 98%. The proportion of minimally invasive techniques, such as thoracoscopic surgery and hybrid procedures, has increased to 35%, and the capacity to treat young (<28 days) and low-birth-weight (<2.5 kg) infants has been significantly enhanced.
In terms of technological breakthroughs, multiple domestic centers have routinely performed complex procedures such as the neonatal arterial switch operation (ASO) and correction of total anomalous pulmonary venous connection. Data released by Shanghai Children's Medical Center in 2023 show that the mortality rate for neonatal ASO has dropped to below 3%, reaching internationally advanced levels. In addition, 3D-printed heart models and computer-simulated surgical planning technologies are becoming increasingly widespread, improving the precision of correction for complex malformations.
Background and Significance
Congenital heart disease is the most common birth defect in China, with an incidence rate of approximately 8 per 1,000, adding about 150,000 new cases each year, of which about one-third require surgical intervention during the neonatal or infant period. Over the past decade, congenital heart disease surgery in China has evolved from primarily correcting simple malformations to a comprehensive treatment system covering complex and critical conditions. The National Health Commission has included congenital heart disease in the special treatment program for major diseases, promoting tiered diagnosis and treatment and the construction of regional medical centers, thereby facilitating the dissemination of technology. The "China Congenital Heart Disease Surgical Treatment Quality Control Report" released in 2023 shows that among participating hospitals, the proportion of neonatal surgeries increased from 12% in 2018 to 18%, and the complication rate decreased by 30%.
Significance for International Patients
For international patients, the progress in neonatal congenital heart disease surgery in China means more options. Compared with Europe and the United States, the treatment success rates at top Chinese centers are comparable, but costs are significantly lower—for example, neonatal ASO surgery at Shanghai hospitals partnered with MedBridge costs about one-third to one-half of that in Western countries. At the same time, Chinese centers have accumulated extensive experience with complex cases, particularly excelling in malformations such as double outlet right ventricle and total anomalous pulmonary venous connection. Furthermore, international patients can benefit from China's increasingly comprehensive international medical support services, such as visa fast-track channels, multilingual medical coordination, and postoperative remote follow-up.
How MedBridge Helps
MedBridge Shanghai, as a cross-border medical platform, is dedicated to connecting international patients with top Chinese cardiovascular centers. We collaborate with institutions such as Shanghai Children's Medical Center and Children's Hospital of Fudan University, providing full support for neonatal congenital heart disease surgery, including cost estimation, medical record pre-review, expert consultation appointments, travel arrangements to China, and postoperative follow-up. The platform has successful experience in treating hundreds of international pediatric patients, covering complex procedures such as ASO and Norwood. Our medical consultant team provides services in multiple languages, including Chinese, English, and Arabic, and assists with medical visa applications. If you or your relatives and friends need related assistance, please feel free to contact us or view details of medical services.
Related reading: List of Partner Hospitals in Shanghai